Cathie Wood's $362 Million CRISPR Bet: Hidden Catalyst
Cathie Wood’s big bet on CRISPR Therapeutics signals more than faith in gene editing. This article digs into the unde...
If your budget isn't functioning, it's time for a change. Explore effective strategies to fix your budget and regain control of your finances.
13,885 articlesCathie Wood’s big bet on CRISPR Therapeutics signals more than faith in gene editing. This article digs into the unde...
If the Fed delivers a single rate move in 2026, bond ETFs could react in surprising ways. This article explains what ...
Sai debuts Sai Perps, a perpetuals platform marrying rapid trading with on-chain settlement. A month-long Saicho cont...
CEOs confront a defining moment as AI and rapid tech adoption reshape how growth and work interact. This report outli...
Vistra surged dramatically, but does the rally leave room for gains or is the stock now a trap for late buyers? This ...
Finding winning stocks isn’t about chasing the hottest trend. It’s about identifying durable catalysts, solid fundame...
When conviction runs hot but capital is capped, traditional 1:1 bets may feel limiting. The forget returns: double-le...
A fresh $75 million fund backs consumer brands with cultural punch. The 29-year investor went from early, risky bets ...
Coinbase teams up with Yahoo Finance to let all U.S. users trade crypto directly from Yahoo asset pages. The move bro...
When Amazon signaled massive AI and data center investments, its stock tumbled. This guide explains why that drop cou...
Tariff headlines keep markets guessing. This guide shows how two Vanguard index funds outperformed the S&P 500 in 202...
CoreCivic has faced a share-price headwind even as revenue climbs. A notable $5 million stake by Hahn Capital signals...